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MicroRNAs: Not “Fine-Tuners” 
but Key Regulators of Neuronal 
Development and Function
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Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Department of Anatomy and 
Developmental Biology, Monash University, Melbourne, VIC, Australia
MicroRNAs (miRNAs) are a class of short non-coding RNAs that operate as prominent 
post-transcriptional regulators of eukaryotic gene expression. miRNAs are abundantly 
expressed in the brain of most animals and exert diverse roles. The anatomical and 
functional complexity of the brain requires the precise coordination of multilayered gene 
regulatory networks. The flexibility, speed, and reversibility of miRNA function provide 
precise temporal and spatial gene regulatory capabilities that are crucial for the correct 
functioning of the brain. Studies have shown that the underlying molecular mechanisms 
controlled by miRNAs in the nervous systems of invertebrate and vertebrate models 
are remarkably conserved in humans. We endeavor to provide insight into the roles 
of miRNAs in the nervous systems of these model organisms and discuss how such 
information may be used to inform regarding diseases of the human brain.
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iNTRODUCTiON
MicroRNAs (miRNAs) are non-coding RNA molecules with a length of approximately 22 nucleo-
tides, which act as post-transcriptional regulators of gene expression (1–4). Discovered just over two 
decades ago, miRNAs have been found to be abundant in most organisms and critically important for 
post-transcriptional control of mRNAs by regulating a predicted 60% of protein-coding genes (5). 
Prior to the discovery of the miRNA pathway, the lin-14 gene in Caenorhabditis elegans was shown to 
be regulated by a 22-nucleotide partially complementary strand of RNA called lin-4 (6, 7). However, 
a mechanistic understanding of this process remained unclear until the let-7 gene was shown to 
encode a complementary sequence of lin-41 to regulate developmental timing (8). This led to a 
paradigm shift in how mRNA regulation was viewed, and further investigation demonstrated that 
the miRNA pathway was evolutionarily conserved in most eukaryotes (9). Since then miRNAs have 
been shown to be required for key biological processes, such as cell fate, differentiation, apoptosis, 
and tumor suppression (10–13).
The process of miRNA biogenesis in animals can be briefly simplified into three fundamental steps 
(Figure 1) [for detailed review, see Ref. (14)]. First, double-stranded primary miRNA (pri-miRNA) 
short hairpin structures are transcribed by RNA polymerase II. Secondly, a nuclear-localized RNA 
endonuclease III, Drosha, defines one end of the pri-miRNA duplex and cleaves double-stranded RNA 
(dsRNA) transcripts into approximately 70 nt stem loops called precursor mRNAs (pre-miRNAs) 
(15). These pre-miRNAs are exported to the cytoplasm by Exportin-5 (XPO5) (16) where the Dicer 
enzyme cleaves pre-miRNA sequences into 21–23 nt mature miRNA double-stranded duplexes (17). 
Such miRNA duplexes load into a pre-RISC (pre-miRNA-induced silencing complex) which is a 
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complex of Argonaute (AGO) and other proteins (18). Within 
the pre-miRISC, the “passenger” strand is removed leaving just 
the “guide” strand in the mature miRISC. The guide strand is nor-
mally the strand with a more thermodynamically unstable 5′ end 
(19). The released passenger strand is either degraded or loaded 
into a different miRISC complex to regulate a different group of 
target transcripts to the guide strand. The miRISC complexes 
then scan the transcriptome for partially complementary mRNA 
sequences. The miRNA then associates with a target mRNA by 
imperfect base-pairing, on the most part, to its 3′UTR and medi-
ates post-transcriptional repression (PTR) or decay of specific 
mRNA targets (17, 20). The partially complementary sequences 
of miRNAs allow them to recognize and inhibit the expression of 
multiple mRNA transcripts (21). mRNA recognition is primar-
ily determined through nucleotides 2–7 of the 5′ end or “seed” 
region of miRNAs (3). miRNAs can also initiate mRNA degrada-
tion by recruiting the mRNA degradation machinery, or through 
the use of cytoplasmic RNA granules known as Processing bodies 
(P-bodies), which can degrade mRNAs via cap removal and 5′–3′ 
exonuclease activity (22).
FiGURe 1 | The miRNA pathway. Primary miRNAs (pri-miRNAs) are 
transcribed from the genome and form hairpin structures. Nuclear-localized 
Drosha endonuclease cleaves pri-miRNAs into approximately 70 nt precursor 
miRNAs (pre-miRNAs) which are then transported from the nucleus to the 
cytoplasm by Exportin-5 (XPO5) via the nuclear pore complex, where they 
are further cleaved by Dicer into mature 21–23 nt miRNA fragments. Once 
the strands separate, the guide strand is loaded into the RISC complex (AGO 
and different cofactors) to scan the transcriptome for partial complementary 
target transcripts. These sequences are either repressed by the RISC 
complex or degraded in P-bodies.
As mentioned above, the nature of miRNA targeting through 
imperfect complementarity means that single miRNAs have the 
potential to regulate the expression of hundreds of genes (3). In 
addition, certain genes have multiple miRNA-binding sites in 
their 3′UTRs and, therefore, multiple miRNA families potentially 
control their expression (3). 3′UTR length is often a determining 
factor as to its propensity to miRNA regulation (3). Such complex 
relationships between miRNAs and their targets enable exquisite 
control of gene regulatory networks. A better understanding of 
miRNA function in the control of such gene regulatory networks 
has been accelerated by the use of simple model organisms, such 
as C. elegans and Drosophila. Studies using these models are aided 
by their genetic amenability, short lifespans, and compact genomes. 
However, there are multiple mammalian-specific miRNAs for 
which the use of higher eukaryotes is required to study their biology.
FUNCTiONS OF miRNAs iN THe 
NeRvOUS SYSTeM
The human brain contains approximately 86 billion neurons and 
trillions of synaptic connections (23). This complex organ is an 
integration center where environmental information is processed 
and used to make an appropriate action or decision. To effect brain 
function as a whole, neurons are organized into circuits which 
communicate with each other through rapidly acting synaptic 
connections and slower acting neuropeptide release. An inability 
to regulate these molecular communication processes is causative 
in developmental disorders, such as autism and schizophrenia, 
in addition to age-related decline of brain function (24, 25). 
Therefore, using model organisms to dissect these mechanisms at 
a molecular, anatomical and functional level will provide a greater 
understanding of neuronal-based disease.
The ability of the nervous system to adapt to different envi-
ronmental conditions and stimuli requires a well-conserved 
and flexible repertoire of molecular mechanisms. miRNAs offer 
genetic networks’ additional layers of regulatory control and are 
abundantly expressed in all human tissues, including the brain 
(26). In addition to this, many miRNAs display specific temporal 
and spatial patterns of expression (27). Due to the high degree of 
complexity of the human brain, in addition to ethical concerns, 
deep mechanistic understanding of how miRNAs influence neu-
rodevelopmental and functional processes has come from model 
organisms. This review aims to provide examples that reveal the 
important roles of miRNAs in the development and function of 
the nervous system (Figure 2). We focus on the crucial role model 
organism research has played in this area to provide insight into 
the functions of miRNAs.
miRNA ReGULATiON OF THe NeRvOUS 
SYSTeM iN iNveRTeBRATeS
Caenorhabditis elegans
The initial discovery of miRNAs was made in the nematode 
C. elegans and, since that time, many fundamental studies 
implicating miRNAs in gene regulatory networks significant 
to neurodevelopment have been achieved using this model 
FiGURe 2 | Roles of miRNAs in different stages of neuronal development. miRNAs are involved in the multiple stages of neuronal development in 
invertebrates and vertebrates. Listed here are the miRNAs we cover in this review that regulate single or multiple stages of neuronal development. cel, 
Caenorhabditis elegans; dme, Drosophila melanogaster; dre, Danio rerio; hsa, Homo sapiens; mmu, Mus musculus; xtr, Xenopus tropicalis.
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(28–30). C. elegans has proven demonstrative as many miRNAs 
are highly conserved throughout evolution, along with other 
well-known advantages of the model organism including its 
well-defined neuronal lineage map, neuroanatomy, and neural 
networks (31–35).
MicroRNAs have been shown to participate in instructing 
cell fate decisions made during the development of the nervous 
system of C. elegans. For example, the ASE neurons are a pair of 
morphologically similar, asymmetric gustatory sensory neurons, 
which have different roles: ASEL senses sodium, while ASER 
senses chloride (36). The neuron pair is derived from different 
lineages, which diverge at the four-cell stage of embryogenesis. A 
complex gene regulatory pathway, in which the miRNA lsy-6 plays 
a central role, essentially achieves the specification of this pair of 
neurons during development. The Nkx homeobox transcription 
factor COG-1, which induces ASER fate, is inhibited by lsy-6 in 
ASEL (37–39). It was subsequently shown that lsy-6 expression 
itself is controlled by a complex mechanism involving two regu-
latory elements, firstly where transcription factors TBX-37/38 
“prime” the lsy-6 locus for expression by altering chromatin to an 
open state. Expression is then “boosted” by the transcription fac-
tor CHE-1, and lsy-6 induces gene expression changes associated 
with asymmetrical generation of the ASEL and ASER neurons 
(40). This “priming” and “boosting” of lsy-6 begins several cell 
divisions prior to the specification of ASEL neuron and is the first 
asymmetrically expressed gene in the ASEL and ASER neurons. 
This mechanism resulting in bilateral symmetry in the nervous 
system may provide important insights into how symmetry is 
established in the mammalian brain.
mir-71 is another miRNA involved in neuron specification in 
C. elegans. mir-71 controls cellular responses to calcium to specify 
asymmetry in function of the morphologically symmetrical 
AWCON and AWCOFF olfactory neurons (41). mir-71 controls this 
signaling pathway as it is expressed at a higher level in one neuron 
of the pair, which negatively regulates the calcium adaptor protein 
TIR-1/Sarm1 downstream of nsy-4/claudin and nsy-5/innexin, 
to specify the AWCON neuron (41). Interestingly, for this pair of 
neurons, cell fate is not rigid. That is, whether the left or right 
neuron is specified AWCON is not fixed, and if the AWCON is lost, 
AWCOFF can convert to AWCON (41).
Aside from neuronal specification, evidence from C. elegans 
indicates that miRNAs are involved in gene regulation to control 
neuron migration and differentiation. It was demonstrated that 
a regulatory pathway essential for normal neuron migration and 
axon guidance involves mir-79 (an ortholog of mammalian miR-
9) (42). In C. elegans, loss of mir-79 from epidermal cells caused 
an increase in expression of SQV-5 (a chondroitin synthase) and 
SQV-7 (a UDP-sugar transporter), both required for the biosyn-
thesis of glycosaminoglycan (GAG) chains that are attached to 
proteoglycans (43). Defective regulation of SQV-5 and SQV-7 
in the epidermis caused striking defects in the migration of 
hermaphrodite-specific neurons (HSNs). RNAi knockdown 
of sqv-5 and sqv-7 in mir-79 deletion mutant animals restored 
the incidence of HSN defects to background levels. Additional 
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work showed that this mechanism is required to regulate the 
addition of heparan sulfate chains on a glypican called LON-2. 
This work, therefore, defined a pathway through which mir-79 
expression in epidermal cells non-cell autonomously controls 
HSN migration (42).
Netrin-mediated axon guidance is also influenced by miRNA 
expression in C. elegans to ensure the correct timing of axon ter-
mination. Cell autonomous expression of lin-4 (homologous with 
miR-125a/b) targets the transcription factor lin-14 at completion 
of extension of the anterior ventral microtubule (AVM) axon, to 
inhibit netrin-mediated axon attraction (44). Such temporal loss 
of responsiveness is due to decreased expression of the netrin 
receptor UNC-40 through lin-4-mediated reduction of LIN-14. 
The cell-autonomous regulation of lin-14 by lin-4 is also required 
for the timing of axon extension of the HSNs (29). In lin-4 loss of 
function animals, the HSNs do not extend their axons prior to the 
larval-adult transition, and adult axons have defective morphol-
ogy. Therefore, lin-4 is required to temporally regulate extension 
of axons in two neuronal paradigms in C. elegans (29).
Later in neuronal development, miRNAs also control synap-
togenesis and remodeling in C. elegans. For example, lin-4 targets 
lin-14 to remodel motor neuron synapses during the first larval 
stage L1, when motor neurons eliminate their synapses with ven-
tral muscles and instead form connections with dorsal muscles. 
The timing of this change is regulated by the heterochronic genes 
lin-4–lin-14 (28) and mir-84–hbl-1 (45). mir-1 also plays important 
roles in synaptic function, by targeting the transcription factor 
MEF-2 to control neurotransmitter release at the neuromuscular 
junction (NMJ) (46). mir-1 also targets synaptic proteins neuroli-
gin and neurexin (47), which in humans are two synaptic proteins 
that have been linked with defects in synaptic function associated 
with autism spectrum disorders (ASDs) (48). Elucidating these 
mechanisms in C. elegans may reveal conserved pathways and 
provide important insights into human development and mecha-
nisms underlying neurodevelopmental disorders.
Interestingly, miRNAs have also been implicated in the 
 developmental decline of regenerative ability of the nervous sys-
tem. The miRNA let-7 is only expressed very weakly when initial 
axonogenesis occurs, and onset of expression with age contributes 
to a reduced capacity for regeneration of the AVM neurons (30). 
This mechanism involves a developmentally regulated loop includ-
ing the TRIM protein LIN-41, among other factors. The exciting 
discovery that suppression of let-7 could restore regenerative 
capacity (30) could be conserved in vertebrates, and indeed it has 
since been shown that suppression of Let-7 in primary cultured 
rat peripheral neurons increases their regenerative response (49).
Finally, the miRNA mir-71 was found to regulate the physiol-
ogy of C. elegans non-cell autonomously from the nervous system 
(50). The authors showed that mir-71 expression in the AB line-
age (nearly all neurons) is necessary and sufficient for lifespan 
extension of animals lacking a germline (50). The authors showed 
that neuronal mir-71 regulates the localization and activity of the 
FOXO transcription factor DAF-16 in the intestine which acts 
downstream of insulin-like signaling to regulate metabolism and 
stress responses (50–52). Such non-cell autonomous regulation 
of intestinal DAF-16 by mir-71 is via an, as yet, unidentified 
neuronal factor.
Drosophila melanogaster
MicroRNAs in the fruit fly, Drosophila melanogaster, have been 
extensively investigated in various developmental processes 
[reviewed in Ref. (53)]. miRNAs are critical for all aspects of neu-
ronal development, from regulating neural stem cells to regulating 
the events that occur at the NMJ. For example, control of neuronal 
progenitor proliferation is fine-tuned by the highly conserved 
miRNA, miR-124, which has been shown in various organisms to 
regulate neuronal stem cells (54–57). In Drosophila, mir-124 tar-
gets anachronism (ana), an inhibitor of neuroblast proliferation. 
The absence of miR-124 results in decreased proliferative activity, 
which is coupled with an increase in ana expression (58). In addi-
tion to this, miR-124 is required for optimal regulation of dendrite 
growth and targets components of the retrograde BMP signaling 
pathway to regulate synaptic release at the NMJ (59).
Additional miRNAs that contribute to neuronal proliferation 
are the fly homologs of mammalian miR-92 and miR-200 – miR-
92a/b and miR-8, respectively (60, 61). miR-92a is located in the 
intron and miR-92b in the 3′UTR of a putative DNA-binding 
protein, jigr1, and they suppress this host gene to regulate neural 
stem cell development to prevent premature differentiation (61). 
Additionally, miR-8 has been implicated in regulating neuronal 
proliferation but is expressed in a glial cell population ensheath-
ing the optic lobe neurepithelium (60). In the latter of these roles, 
miR-8 is required for the temporal and spatial control of EGFR 
pathway ligand, Spitz, which controls accurate neuroepithelial 
proliferation and neuroblast formation (60).
Drosophila has been used as a model to identify miRNAs that 
temporally and spatially control neuronal differentiation and 
specification. An example of this is with olfactory neuronal mor-
phogenesis, which is associated with accurate miRNA function. 
Loss of core components of the miRNA biogenesis machinery, 
including Pasha or Dicer, results in abnormal olfactory neuron 
morphogenesis (62). The basis for these defects was defined by 
studies of the mushroom body neurons (MB), which mediate 
olfactory responses and comprise of four invariant subtypes of 
neurons in various insects (63–66). The generation of MB neurons 
requires tight post-transcriptional regulation of the BTB-zinc 
finger chronologically inappropriate morphogenesis (chinmo) in 
postmitotic neurons (66). This is achieved by a group of miRNAs 
that are cotranscribed from a single locus and comprise of miR-
125, miR-100, and the highly conserved let-7, collectively referred 
to as the let-7-Complex (let-7-C) (67). The initial discovery of let-7 
in C. elegans identified a heterochronic role for let-7, whereas in 
Drosophila let-7 expression is not enriched in early development, 
but upregulation of let-7-C is associated with a downregulation 
of chinmo (68). This suggests that the mechanism identified in 
C. elegans where let-7 regulates developmental timing functions 
in a different context in Drosophila to regulate the formation of 
MB neurons.
The involvement of miRNAs in dendrite growth is unclear, 
although a small number of studies in Drosophila have identified 
two miRNAs required for dendrite growth of sensory neurons. 
First, the miRNA, bantam, has been implicated in dendrite scal-
ing by suppressing Akt kinase activity in nearby neurons and by 
regulating epithelial endoreplication (69, 70). Secondly, miR-9a 
(mammalian miR-9 homolog) acts from epithelial cells to fine-tune 
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dendrite growth. This is achieved by regulating the activity of a 
cadherin-domain containing putative G-protein-coupled receptor, 
Fmi, which functions to suppress dendrite growth (71). miR-9a 
also acts with miR-7 to control the development of sensory organs. 
In Drosophila, sensory organs develop from single organ precursor 
cells (SOPs), which are generated from clusters of cells expressing 
proneural genes. This process is temporally controlled by Notch 
signaling and two transcription factors that regulate proneural gene 
expression. These consist of Senseless, a positive regulator of SOP 
cells, which is targeted by miR-9a, and a negative regulator, Enhancer 
of Split, which is targeted by miR-7 (72–74). Furthermore, miR-9a 
is also influenced by the RBA-binding protein, TDP-43, mutants of 
which display increased SOP cells coupled with decreased miR-9a 
expression (75). Although the exact requirement of TDP-43 in 
this process is unclear, genetic interaction assays suggest that SOP 
specification requires TDP-43 for accurate neuronal differentiation 
by influencing miR-9a activity.
MicroRNAs have also been shown to regulate the NMJ in 
Drosophila embryos and larvae. miR-8 and miR-289 are required 
to suppress activity-dependent synaptic growth by targeting genes 
involved in axon development and growth. miR-8 downregulates 
wingless, a presynaptic regulatory protein required for activity-
dependent axon terminal growth at the NMJ (76). In this context, 
miR-8 regulates the timing of synaptic expansion to correlate 
with the growth of target muscles. Furthermore, miR-8 regulates 
the embryonic expression of two synaptic immunoglobulin 
superfamily cell adhesion molecules (IgCAMs), Fasciclin III 
(FasIII), and Neuroglian (Nrg) (77). Taken together, these studies 
lay a foundation for further study into the role(s) of miR-8 in 
presynaptic events, as well as the timing of synaptic assembly with 
neuron–muscle association.
Finally, miR-8 has also been shown to regulate apoptosis in 
the CNS of Drosophila (78). miR-8 regulates the expression of 
the transcriptional corepressor Atrophin to a particular thresh-
old level. Loss of miR-8 results in increased atrophin levels and 
apoptosis; however, reduction of atrophin expression below the 
threshold set by miR-8 causes extra tissue being generated (78). 
Precise tuning of atrophin levels is, therefore, required to prevent 
neurodegeneration in the CNS of Drosophila.
miRNA ReGULATiON OF THe NeRvOUS 
SYSTeM iN veRTeBRATeS
Xenopus laevis
Neuronal development and function have been extensively 
studied in the Xenopus laevis tadpole [reviewed in Ref. (79)]. 
However, in contrast to other model organisms, the influence of 
miRNAs during neurodevelopmental processes has received less 
attention. Nevertheless, certain conserved miRNAs investigated 
in Xenopus offer new insights to their function. For example, 
similar to other model organisms, miR-124 regulates early neu-
rogenesis. However, in Xenopus, miR-124 is expressed from the 
beginning of eye development where it plays an important role in 
regulating retinal neurogenesis in the optic vesicle and forebrain 
(57, 80, 81). In addition to this, miR-129, miR-155, miR-214, and 
miR-222 contribute to developmental timing of retinal progenitor 
cells by regulating the activity of the transcription factors, xotx2 
and xvsx1, which are both required for promoting the late-stage 
progenitor cells to differentiate into bipolar neurons (82).
The highly conserved miR-9 is also required for neurogenesis 
along the anterior–posterior axis by targeting the transcription 
factor, hairy1, although its function varies from the hindbrain 
to the forebrain. In the forebrain, regulation of hairy1 by miR-9 
influences proliferation of neural progenitor cells through Fgf8 
signaling, but via Wnt signaling in the hindbrain (83). This sug-
gests positional specificity regarding miR-9 function. Defects 
associated with the nonsense-mediated mRNA decay (NMD) 
pathway result in neurological disorders in humans (84, 85). 
Interestingly, in Xenopus, miR-128 has been shown to repress 
NMD by targeting the RNA helicase, UPF1, and the exon-junction 
cofactor, MLN51 (86). This process allows upregulation of spe-
cific mRNAs required for differentiating neuronal cells, which are 
normally targeted by NMD. Moreover, this mechanism is highly 
conserved in mammals and represents a dual mRNA regulatory 
network to maintain neuron development and function (86).
Danio rerio
Danio rerio (zebrafish) is a valuable model system that has been 
used to uncover neurodevelopmental functions for miRNAs, 
with the advantage that zygotic loss of miRNAs can be examined 
in the absence of maternal compensation mechanisms, since the 
zygote develops outside of the mother (87). Embryos carrying dicer 
mutations display severe developmental defects, including delayed 
embryogenesis, perturbed neurulation, and formation of brain 
ventricles, as well as ill-defined anatomical boundaries, such as the 
midbrain-hindbrain boundary (MHB) (87). However, interestingly 
the same study also showed that despite the gross morphological 
defects, gene expression, and neuron specification were maintained 
within patterned regions, such as the forebrain and hindbrain 
rhombomeres. Later stage neuronal differentiation, such as axon 
extension, was also severely affected by loss of dicer (87).
In zebrafish, miRNAs are expressed in neural cells throughout 
the different stages of development in addition to in mature 
neurons. They can have ubiquitous or cell-specific expression pat-
terns. Many conserved miRNAs are expressed at the same devel-
opmental timepoints as other vertebrates, for example, miR-9 and 
let-7 are expressed in both proliferating and differentiating cells 
(88). As in C. elegans, lin-28 and its downstream heterochronic 
genes let-7 and lin-4/miR-125b are expressed during development 
to coordinate cell proliferation (89).
In zebrafish hindbrain development, miR-107 stabilizes dicer 
levels, which maintains a specific level of miR-9 biogenesis to 
regulate optimal proliferation of neural progenitors (90). miR-9 
inhibits proliferation at the MHB and hindbrain ventricular zone 
through targeting of proproliferation genes her5, her6/Hes1, 
and zic5 and then later also influences neuronal maturation by 
regulating elav3/HuC (91–93). Additionally, miR-9 overexpres-
sion causes a strong reduction in the MHB and cerebellum, as 
well as blurred somatic boundaries and altered cell fates, through 
downregulation of fgfr1 in the Fgf signaling pathway (91).
More recently, zebrafish hindbrain development has been used 
as a model system to uncover precise mechanisms of the miRNA-
mediated mRNA decay pathway (94). In this study, a genetic screen 
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implicated cnot8, which was known to have deadenylase activity 
in polyA tail removal in mRNA turnover. Furthermore, the role 
of cnot8 in the Fgf signaling pathway is responsible for hindbrain 
dopaminergic neuron differentiation, and application of a drug 
inhibiting Fgf signaling partially restored the mutant phenotype 
(94). Zebrafish studies also elucidated the mechanisms through 
which morphine influences dopaminergic neuron differentiation, 
since maternal influence can be removed from developmental 
events. Morphine downregulates miR-133, which increases pitx3 
expression thereby promoting dopaminergic neuron maturation 
(95). This study revealed important information relating to neural 
networks involved in drug addiction.
In the later stages of zebrafish neurodevelopment, miR-430 
controls trigeminal sensory neuron migration. These sensory 
neurons arise from the neural crest and placodes, and their 
migratory journey of up to 120  μm requires the chemokine 
SDF1a and its receptor Cxcr4b. The border of SDF1a expression 
shifts continually to make a tightly regulated chemotactic path for 
neurons to migrate, and miR-430 is important for clearing SDF1a 
from the pathway that neurons have passed through (96).
Finally, in zebrafish embryos, miRNAs are also involved in 
dendritic spine formation and synaptogenesis. For example, 
knockdown of miR-153 caused a sevenfold increase in spontane-
ous body movement, and the synaptic protein SNAP-25, which is 
involved in vesicular exocytosis, was found to be the target (97).
Mus musculus
The earliest mammalian studies following the discovery of 
miRNAs in C. elegans quickly demonstrated the crucial nature 
of the class of non-protein-coding RNAs in mammals through 
the generation of mice carrying deletions for miRNA-processing 
pathway components including Dicer, Dgcr8, and Argonaute. 
Argonaute proteins are essential components of the RISC com-
plex, facilitating translational inhibition or target mRNA cleavage, 
and Argonaute 2 mutants show an early and severe neurodevel-
opmental phenotype, with neural tube closure failing to occur 
(98). Deletion of another component of the miRNA-processing 
pathway, Dgcr8, causes microcephaly in mutant mice but is much 
less severe than loss of Dicer mutants (99). Under investigation 
is the potential importance of Dgcr8 in Di George syndrome, a 
multifaceted disorder where 30 genes including Dgcr8 are deleted, 
and has been associated with schizophrenia (100).
Loss of Dicer causes lethality in lower eukaryotes, such as C. 
elegans and Drosophila (101, 102). However, the neurodevelop-
mental consequence of Dicer loss in mice has been investigated 
in greater depth using conditional deletion mutants (103, 104). 
This led to further confirmation of both the spatial and temporal 
importance of miRNA-mediated pathways in multiple phases of 
mammalian CNS development. One study used conditional Dicer 
deletions generated with Emx-Cre (excitatory cerebral cortex 
neurons) and Nestin-Cre (all CNS neurons) mouse lines at dif-
ferent stages of embryonic cerebral cortex development showed 
that miRNAs are important for three major phases of cerebral 
cortex development: neuronal progenitor proliferation, neuronal 
migration, and differentiation (105).
Conditional mutants have been further used to confirm the 
importance of miRNAs in the progression of cerebral cortex 
development, with Cre-recombinase-driven deletion of Dicer 
under the control of Foxg1, Emx1, Nes, Nex, and CamkII pro-
moters (106). These models have shown that in the early stages of 
cerebral cortex development, conditional deletion leads to a loss 
of neurons, either due to loss of the neural progenitor pool or 
increased apoptosis. Deletion of Dicer leads to neuron migration 
defects and impaired cellular differentiation, as well as cell fate 
changes and cortical lamination defects (106).
Conditional deletion of Dicer from the embryonic day 8 (E8) 
telencephalon causes a loss of radial glial progenitor markers, 
including nestin, Sox9, and ErbB2, which then results in an 
increase in basal progenitors and postmitotic neurons (107). 
Interestingly, increased apoptosis was also observed, and this 
was correlated with reduced expression of miR-9 and miR-124 
(107), two miRNA families that have been widely implicated in 
brain development. Dicer conditionally deleted using the Nex-
Cre promoter (targeting neurons of pyramidal fate) resulted in 
significantly smaller mouse brains, due to increased packing 
density of neurons, as well as abnormal neuron differentiation, 
but no defect in neuron production or cortical lamination (107). 
Conditional deletion of Dicer by α-CaMKII-Cre in the embry-
onic forebrain resulted in microcephaly due to increased apop-
tosis, rather than neuronal migration defects, since lamination 
appeared unaffected. Reduced dendritic branching and dendritic 
spine development was also observed (103), along with ataxia and 
reduced life span. Interestingly, Dicer deletion in neural crest cells 
(by Wnt1-Cre) does not affect migration and early differentia-
tion, but miRNA pathways appear to be required for the survival 
of peripheral nervous system (PNS) neurons, because in Dicer 
deletion mutants PNS neurons are lost after completion of migra-
tion and differentiation due to apoptosis (108, 109). Thus, while 
Dicer mutants all point toward dysregulated nervous system 
development, individual studies have reported slightly different 
mechanisms. Whether this is due to the timing of deletion, the 
promoter driving Cre-recombinase or which miRNAs are being 
lost due to blocking the processing pathway is not clear.
Dicer deletions have been useful in determining the overall 
impact of loss of miRNAs on gene regulation, but more informa-
tion has been gained from studying the roles of specific individual 
miRNAs. The let-7 family, which was one of the first described in 
C. elegans, was subsequently also shown in the mouse to play a 
significant role in maintaining the balance in neuronal progenitor 
proliferation and neurogenesis, since TRIM32 (110) and SOX-2 
(111) influence let-7 levels to maintain cells in a proliferative state. 
let-7b in turn regulates neural stem cell proliferation by targeting 
the stem cell regulators TLX and cyclinD1 (112).
The miR-9 family is one of the most highly conserved and 
abundantly expressed miRNA families in the vertebrate brain and 
is also involved in balancing neural progenitor proliferation and 
controlling progenitor state (93). miR-9 regulates early progenitor 
proliferation in the mammalian brain through the transcription 
factors Hes1 (113), Foxg1, Elav2, Pax-6, as well as Gsh2 (114). 
Confirming its proproliferative role, loss of miR-9 suppresses 
neural stem cell proliferation, through stathmin (115).
The miR-124 family is also conserved from C. elegans to 
humans. It is expressed by differentiating neurons in the subven-
tricular zone of the developing mouse cortex, where it controls 
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apical/basal progenitor progression (56). It is also important for 
continual production of neurons in the subventricular zone of the 
adult mouse brain (116). In neuronal differentiation, miR-124 is 
involved in a mechanism with the transcriptional repressor REST, 
whereby REST represses miR-124a and expression of neuronal 
genes in non-neuronal cells and neural progenitors. But at later 
stages, REST ceases to repress miR-124a, allowing non-neuronal 
transcript degradation and thus promoting neuronal differentia-
tion (117). REST also has miR-124-binding sites in its 3′UTR, 
suggesting a complex regulatory loop exists (118). Another 
transcriptional repressor involved in the REST complex, MeCP2, 
also has predicted miR-124-binding sites in its 3′UTR (118), and 
MeCP2 mutation or copy number variant has been implicated 
in multiple neurodevelopmental disorders including X-linked 
intellectual disability and autism (119, 120).
Therefore, the above-mentioned in  vivo studies suggest that 
miR-9 and miR-124 are major players in the regulation of cerebral 
cortex development, but in vitro studies have shown that miR-9 
and miR-124 can drive the neurogenic program. When Yoo and 
colleagues (121) added miR-9 and miR-124 precursors to cultured 
neonatal foreskin fibroblasts, they were able to directly convert 
them to neurons expressing the mature marker MAP2, albeit 
at a conversion rate of <5%. Neuron conversion was improved 
remarkably by the addition of NEUROD2, ASCL1, and MYT1L, a 
combination that has previously been shown to produce neurons 
(122). Importantly, after 4 weeks in culture, the neurons expressed 
synaptic markers and displayed electrophysiological properties 
consistent with neurons (121). This exciting study suggests that 
miRNAs are not only involved in controlling gene expression in 
neurodevelopment, but could be considered among the master 
regulators of neurogenesis in mammalian cells.
Many other miRNAs have been implicated in the earliest 
stages of mammalian brain development and regulate important 
pathways in development and disease. For example, miR-130b has 
been shown to regulate Fmr1 expression, which is lost in the dis-
order fragile X syndrome. Fmr1 loss causes increased progenitor 
proliferation and altered neuronal fate specification (123). miR-
135a2 regulates Wnt signaling in midbrain dopaminergic neuron 
proliferation in a regulatory circuit with Lmx1b (124), and in the 
mouse cortex, miR-134 promotes neural progenitor cell prolifera-
tion and counteracts apoptosis and differentiation (125). miR-34, 
another conserved miRNA, appears to be linked with neuron 
proliferation, because overexpression of mir-34 in human stem 
cells suppressed the expression of 136 neuronal progenitor genes 
that possess putative miR-34 target sites. Gene ontology showed 
that these genes are overwhelmingly involved in cell motility and 
energy production (126).
In addition to being crucial for neuronal progenitor prolifera-
tion, miR-9 and miR-124 are emerging as key regulators of neuron 
migration. miR-9, along with miR-132, represses Foxp2 to regulate 
radial migration in the developing mouse cortex. Ectopic expression 
of Foxp2 in the developing cortex was counteracted by increased 
endogenous expression of miR-9 and miR-132 (127). In a different 
mechanism, miR-124 and miR-22 regulate cell shape changes in 
migrating cortical neurons by controlling expression of double-
cortin, a microtubule-associated cytoskeleton protein involved in 
cell shape remodeling through multipolar and bipolar phases in 
migrating neurons, through CoREST/REST (128). Recently, the 
miR-379-410 cluster was shown to regulate N-cadherin expression, 
a crucial factor in maintaining tissue structure in the developing cor-
tex. Overexpression of these miRNAs in radial glial cells decreased 
N-cadherin expression, causing increased stem cell differentiation 
and migration (129). miR-128 in the brain regulates Phf6, which 
is a mutated gene in the disorder Borjeson–Forssman–Lehmann 
syndrome, and ectopic expression of miR-228 in the developing 
brain leads to neuron migration defects, neurite outgrowth, and 
electrophysiological changes (130).
Specific miRNAs exhibit increased expression in the latter 
stages of nervous system development in the mouse and are 
implicated in final differentiation, neurite extension, and synapse 
formation. These miRNAs include miR-134 (125, 131) and 
miR-132 (132–134). Also, miR-124 regulates RhoG, which is a 
major player in the control of axon and dendrite outgrowth and 
complexity, in mouse hippocampal neurons (135).
Very recently, expression of a miR-137 gain-of-function 
construct, first in cell lines, and then in the mouse hippocampal 
dentate gyrus, was shown to downregulate three well-known 
presynaptic proteins: complexin-1 (Cplx1), N-ethylmaleimide-
sensitive fusion protein (Nsf), and synaptotagmin-1 (Syt1) (136). 
In  vivo, this was accompanied by fewer synaptic vesicles and 
impaired hippocampal LTP, and impaired hippocampal depend-
ent learning in behavioral testing. Excitingly, some of these defects 
were rescued by codelivery of a miR-137 sponge construct, which 
sequestered endogenous miR-137. These findings and rescue in 
the mouse brain are particularly promising, given the vast data 
implicating miR-137 SNPs in schizophrenia (136).
Homo sapiens
An estimated 70% of all miRNAs are expressed in the human 
nervous system [reviewed in Ref. (137)], although only a small 
number of miRNAs appear to be regulated during neuronal dif-
ferentiation (138). Moreover, temporal and spatial distribution of 
miRNAs in human donor brains, as well as target genes associated 
with neurodevelopmental diseases have been identified (139). 
Despite this, ethical complications prevent in-depth mechanistic 
studies from occurring in humans. Therefore, expression of these 
conserved miRNAs, coupled with mechanistic studies from 
model organisms or cell lines, has allowed for neuronal miRNAs 
to be understood in greater detail [for reviews, see Ref. (140, 
141)]. The majority of investigations in humans use cell lines or 
use screening-based approaches for miRNAs that are associated 
with populations of particular neurodevelopmental disease states. 
Cell line-based approaches, despite their in vitro limitations have 
characterized several miRNAs required for neuronal proliferation 
and differentiation. For example, overexpression of the highly 
conserved miR-9 promotes proliferation of neural progenitor 
cells in human embryonic stem cells (115). miR-9 along with 
miR-124 and miR-125b has also been associated with inducing 
human pluripotent stem cells to differentiate into neurons (142). 
Although described previously in Drosophila and in the mouse, 
miR-9 is a good example of an evolutionary conserved miRNA 
that contributes to various aspects of neuronal development.
Aberrant expression of miRNAs has been associated with 
different neurodevelopmental disorders, such as schizophrenia, 
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autism, Down syndrome, fragile X syndrome, and Rett syndrome 
[reviewed in Ref. (143–145)]. Determining if the aberrant expres-
sion of all of these associated miRNAs is simply the consequence 
of abnormal neuronal development or the cause of the disorder 
itself is challenging. Nonetheless, several studies have identified 
numerous aberrantly expressed miRNAs associated with bipolar 
and schizophrenic patients (146, 147). For example, a contributing 
factor in schizophrenia is decreased function of the N-methyl-
d-aspartate (NMDA) receptor and delivery of NMDA receptor 
antagonists phenocopy the conditions associated with schizo-
phrenia (148–150). Interestingly, miR-132 is downregulated in 
schizophrenic patients and has also been shown to contribute to 
the depolarization of the NMDA receptor (151, 152), suggest-
ing that miR-132 may be a candidate for potential therapeutics. 
Defects associated not only with the expression of key miRNAs, 
but also at a genetic level have been implicated in schizophrenia. 
A genome-wide study of over 40,000 schizophrenic patients 
identified a SNP within the putative coding region of miR-137 
resulting in decreased efficiency of miR-137 function (153). This 
is further supported by additional studies that have shown varia-
tion of miR-137 affects brain activation and function (154–156). 
Unlike examples of differentially expressed miRNAs, miR-137 
suggests a direct genetic-miRNA association with schizophrenia.
Neurological diseases that give rise to ASDs, such as fragile 
X syndrome and Rett syndrome, display elevated and depleted 
miRNA expression [for detailed review, see Ref. (157)]. In addi-
tion to this, mutations associated with the miRNA machinery are 
thought to contribute to the progression of ASDs. For example, 
mutations in the RNA-binding protein, fragile X mental retarda-
tion 1 protein (FMR1), are associated with fragile X syndrome 
patients (158). In Drosophila, FMR1 functions as a RISC cofactor 
to maintain miRNA function (159). Another example is associated 
with Rett syndrome, which is caused by mutations associated with 
the methyl-CpG-binding protein 2 (MECP2) (160), which prevent 
nuclear miRNA processing by regulating the Drosha complex 
(161). Despite the importance of these proteins in human disease 
states, most mechanistic insights regarding FMR1 and MECP2 
have come from investigations employing model organisms. 
Furthermore, these FMR1 and MECP2 studies show how muta-
tions in key proteins associated with miRNA targeting or process-
ing contribute to neurological diseases that give rise to autism.
Screening-based approaches to understand ASD-associated 
miRNAs involve postmortem analysis of autistic patients, as well as 
assessing circulating miRNAs in serum and plasma. This screening 
approach not only has led to a greater understanding of miRNAs 
associated with ASDs but also has potential to use selected miR-
NAs as non-invasive biomarkers for ASDs. Postmortem analysis 
of the cerebellar cortex identified 28 dysregulated miRNAs from 
13 autism patients (162). This included miRNAs that are predicted 
to target the synaptic scaffolding protein, SHANK3, and the 
presynaptic cell adhesion protein, NRXN1, which are both asso-
ciated with ASDs (163, 164). More recently, two studies carried 
out in live patients have identified 13 miRNAs in 55 children, as 
well as five miRNAs in 15 patients in China that are differentially 
expressed in serum and plasma in children with ASDs (165, 
166). These investigations have also revealed the enrichment of 
predicted target genes of these differentially expressed miRNAs 
in various neurological pathways, suggesting a potential use for 
diagnosis and future therapeutic approaches.
CONCLUSiON
Since the initial discovery of miRNAs being involved in devel-
opmental timing of larval development in C. elegans (6, 8, 9), 
small non-coding RNAs have been implicated in a multitude of 
biological processes. lin-4 and let-7 were identified in unbiased 
forward genetic screens, as was lsy-6, the first miRNA shown to 
be involved in the nervous system (38). These genetic approaches 
enabled the identification of miRNAs with very specific roles 
during development. As such, these particular functions may 
have been overlooked when using reverse genetic techniques. 
However, waiting for such chance discoveries takes much time; 
therefore, other approaches are required to systematically drive 
miRNA discoveries forward. With the advent of temporal 
expression pattern analysis, sophisticated RNA sequencing and 
proteomic approaches, and miRNA prediction algorithms, the 
ability to move from a mutation in a specific miRNA to phenotype 
is a possibility using model organisms. Therefore, the meticulous 
scrutiny of miRNA expression patterns and screening for ana-
tomical, functional, and behavioral phenotypes has proved fertile 
ground in the identification of roles for miRNAs in the brain.
In humans, the expression of a number of miRNAs has been 
correlated with neurodevelopmental disorders (143–145); how-
ever, the molecular mechanisms through which they act are not 
understood. Using model organisms as a discovery tool enables 
researchers to study the function of these miRNAs in depth. Due 
to the high degree of conservation between model organisms and 
humans, the elucidation of molecular mechanisms that control 
neuronal development using these models will help identify novel 
therapeutic approaches in the future.
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